Literature DB >> 321158

A defect of the alternative pathway of complement.

J F Soothill, B A Harvey.   

Abstract

The sera of patients defective at opsonization for yeast phagocytosis fix haemolytic complement poorly following incubation with the alternative pathway complement activators, inulin and bacterial endotoxin. This suggests that the defect lies early in the alternative pathway of complement.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321158      PMCID: PMC1540913     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  3 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

3.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

  3 in total
  18 in total

1.  Paediatric Research Society. Plymouth, 15 and 16 September 1978: Abstracts.

Authors: 
Journal:  Arch Dis Child       Date:  1979-02       Impact factor: 3.791

2.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.

Authors:  M Yamamura; H Valdimarsson
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

4.  Impaired opsonization by serum from patients with chronic liver disease.

Authors:  R J Wyke; I A Rajkovic; R Williams
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

5.  Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.

Authors:  D M Roberton; N K Dhanjal; R J Levinsky; J F Mowbray; M W Turner
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Defective yeast opsonization and C2 deficiency in atopic patients.

Authors:  M W Turner; J F Mowbray; B A Harvey; J Brostoff; R S Wells; J F Soothill
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Yeast opsonization in newborn infants and its relationship to parental atopy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

8.  Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.

Authors:  V F Larcher; R J Wyke; L R Davis; C E Stroud; R Williams
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

9.  A common congenital immunodeficiency predisposing to infection and atopy in infancy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

10.  Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.

Authors:  R J Wyke; I A Rajkovic; A L Eddleston; R Williams
Journal:  Gut       Date:  1980-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.